Arcutis Biotherapeutics Inc

9 de out. de 2026, 20:01 UTC

Arcutis Biotherapeutics presents positive ZORYVE data at EADV Congress, showing 34.4% of infants and 66.4% of patients achieving clear skin in trials.

8 de out. de 2026, 20:03 UTC

Arcutis Biotherapeutics Inc shares are gaining.

6 de out. de 2026, 20:00 UTC

Shares of Arcutis Biotherapeutics Inc fell despite the company's ZORYVE® cream winning the 2026 "Best Prescription Skin Solution" Award from Marie Claire magazine.

1 de out. de 2026, 20:07 UTC

Arcutis Biotherapeutics Inc shares fell sharply, continuing a trend of three consecutive lower daily closes amid challenges in the biotechnology sector.

29 de set. de 2026, 20:07 UTC

Arcutis Biotherapeutics launched the "Skin to Believe In" campaign with Simone Biles, as shares fell lower after an initial gain at market open.

28 de set. de 2026, 19:15 UTC

Arcutis Biotherapeutics Inc is trading higher, reaching a peak return of nearly 2% and remaining significantly above its 20-day moving average.

25 de set. de 2026, 20:07 UTC

Arcutis Biotherapeutics Inc is advancing during the session, building on gains since Thursday, trading above its 20-day moving average and near its one-month high.

24 de set. de 2026, 20:07 UTC

Arcutis Biotherapeutics Inc's shares fell, continuing a downward trend since Wednesday, despite earlier fluctuations that saw a pullback from a session high.

23 de set. de 2026, 20:01 UTC

Arcutis Biotherapeutics Inc shares fell sharply, breaking a recent trend of higher daily closes, diverging from the upward movement observed in prior sessions.

22 de set. de 2026, 20:01 UTC

Arcutis Biotherapeutics Inc is advancing sharply, continuing its upward trend since Monday's close, despite an earlier pullback from a session high.

21 de set. de 2026, 23:15 UTC

Arcutis Biotherapeutics Inc declined in after-market trading on Monday, remaining below its earlier low but above its 20-day moving average.

18 de set. de 2026, 22:11 UTC

Arcutis Biotherapeutics Inc is trading modestly lower in after-market hours, continuing a cumulative decline since Friday's close despite a brief uptick earlier.

17 de set. de 2026, 23:16 UTC

Arcutis Biotherapeutics Inc saw a modest decline during after-market hours, despite remaining above its 20-day moving average and near the upper end of its one-month range.

16 de set. de 2026, 23:06 UTC

Arcutis Biotherapeutics Inc is gaining in after-market trading, recovering from earlier declines to peak above the previous close, currently 7.38% above its 20-day moving average.

15 de set. de 2026, 20:07 UTC

Arcutis Biotherapeutics shares are lower today amid a broader market decline following a sharp drop in the NY Empire State Manufacturing Index.

14 de set. de 2026, 20:02 UTC

Shares of Arcutis Biotherapeutics Inc. are advancing, having rebounded from an early session low amid broader market concerns over rising crude oil prices.

11 de set. de 2026, 19:46 UTC

Arcutis Biotherapeutics is gaining today, reaching earlier highs amid broader market reactions to Consumer Price Index data and interest rate speculation.

10 de set. de 2026, 23:06 UTC

Arcutis Biotherapeutics shares are lower in after-market hours, continuing a downward trend observed over the past three sessions. The price remains below the 20-day moving average.

9 de set. de 2026, 19:26 UTC

Arcutis Biotherapeutics is declining amid broader market pressure from rising crude oil prices, which reached $100.49 per barrel during Wednesday's session.

8 de set. de 2026, 23:41 UTC

Arcutis Biotherapeutics shares rose in after-market trading, marking a shift from the recent trend of higher daily closes since Tuesday's close.

4 de set. de 2026, 20:07 UTC

Arcutis Biotherapeutics granted 57,000 RSUs to new employees, supporting growth initiatives. Shares are higher since Thursday's close despite a pullback earlier in the session.

1 de set. de 2026, 20:01 UTC

Arcutis Biotherapeutics Inc. shares are lower today, trading significantly below the 20-day moving average amid rising oil prices and inflation concerns.

31 de ago. de 2026, 19:36 UTC

Arcutis Biotherapeutics Inc shares are higher today, recovering from earlier losses despite no specific news to explain the price movement.

28 de ago. de 2026, 22:56 UTC

Arcutis Biotherapeutics shares are higher in after-market trading, though no specific news was identified. Broader market conditions may influence this movement.

26 de ago. de 2026, 20:08 UTC

Arcutis Biotherapeutics Inc shares are higher Wednesday, pulling back from session highs. Broader market fluctuations follow inflation data indicating rising consumer prices.

25 de ago. de 2026, 19:36 UTC

Arcutis Biotherapeutics shares are gaining as board member Terrie Curran exercised options for 1,072 shares valued at $18,642, according to an SEC filing.

24 de ago. de 2026, 19:16 UTC

Arcutis Biotherapeutics Inc. shares are trading lower, continuing a downward trend amid broader market dynamics and ahead of upcoming macroeconomic developments.

21 de ago. de 2026, 19:56 UTC

Arcutis Biotherapeutics Inc. is trading lower despite Health Canada's approval of PrZORYVE® cream for pediatric atopic dermatitis. The stock continues a downward trend since Thursday.

20 de ago. de 2026, 19:51 UTC

Arcutis Biotherapeutics Inc shares are lower despite Health Canada approving ZORYVE cream for pediatric atopic dermatitis, amid broader Biotechnology sector weakness.

19 de ago. de 2026, 19:26 UTC

Shares of Arcutis Biotherapeutics Inc. are higher today, maintaining an upward trajectory despite a modest pullback from an early high earlier in the session.